Results 101 to 110 of about 9,441 (182)

Heart Substructure Radiation Dose and Cardiac Outcomes: Contemporary Evidence and Actionable Opportunities: JACC CardioOncology State-of-the-Art Review. [PDF]

JACC CardioOncol
Atkins KM, Walls G, Nikolova AP, Ferrall J, Oorloff M, Bychowski J, Kolb K, Karlstaedt A, Mitchell JD, Mak RH, Bergom C.   +10 more
europepmc   +1 more source

Utility of Yttrium-90 Radioembolization for the Treatment of Fibrolamellar Hepatocellular Carcinoma: A Tertiary Cancer Center Experience. [PDF]

J Hepatocell Carcinoma
Khavandi MM, Agahi KN, Lee SS, Kaseb AO, Odisio BC, Abdelsalam ME, Kuban JD, Sheth RA, Avritscher R, Kappadath SC, Mahvash A, Habibollahi P.   +11 more
europepmc   +1 more source

^99mTc MAA SPECT/CT pre-treatment based surrogate dosimetry and hepatotoxicity in patients following ⁹⁰Y radioembolization: association of non-tumor liver dose and clinical markers of radioembolization induced liver disease (REILD). [PDF]

Quant Imaging Med Surg
Bassir A, Dang C, Chiu K, Gampala S, Loon T, Salaskar A, Kobayashi K, Krol A, Lubin DJ.   +8 more
europepmc   +1 more source

Understanding Current Trends and Advances in Transarterial Radioembolization Dosimetry. [PDF]

Diagnostics (Basel)
Young S, Naser-Tavakolian K, Sajan A, Reis S, Woodhead G, Sandow T, Gimenez J, Garcia-Reyes K, Berman Z, Krishnasamy VP.   +9 more
europepmc   +1 more source

Theranostics in Sarcoma: A Critical Review of Current Evidence and Future Potential. [PDF]

Curr Treat Options Oncol
Appana O, Konieczkowski D, Tinoco G.
europepmc   +1 more source

Development and clinical deployment of an automated planning tool for prostate only and male whole pelvis plans based on multi-criteria optimization. [PDF]

J Appl Clin Med Phys
Huang K, Wang K, Schrum A, Kusmaul E, Fisler E, Guerrero M.   +5 more
europepmc   +1 more source

Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinoma. [PDF]

Hepatol Commun
Núñez K, Núñez K, Hasani N, Cronan J, Gimenez J, Cohen A, Sandow T, Thevenot P.   +7 more
europepmc   +1 more source

Meta-analysis of efficacy and safety of Yttrium-90 radioembolization (TARE) in the treatment of advanced hepatocellular carcinoma. [PDF]

Front Nucl Med
Lin H, Tan Q.
europepmc   +1 more source

Fast [¹⁷⁷Lu]Lu-PSMA SPECT/CT with dual-energy acquisition and Monte Carlo-based scatter correction. [PDF]

EJNMMI Phys
Könik A, Auer B, Krauthammer SH, Ravi P, Ng TSC, Jacene HA.   +5 more
europepmc   +1 more source

Radiological Loco-Regional Treatments for Cholangiocarcinoma: A Systematic Review of the Literature. [PDF]

Liver Int
Pallas D, Campani C, Sutter O, Nahon P, Ganne-Carrié N, Seror O, Nault JC.   +6 more
europepmc   +1 more source